1 Min Read
Oct 24 (Reuters) - EQL PHARMA AB:
* EBITDA FOR Q3 AMOUNTED TO SEK 0.9 (0.4) MILLION, AN INCREASE OF 120% Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.